363 related articles for article (PubMed ID: 7033781)
1. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
Murray BE; Rensimer ER; DuPont HL
N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
[TBL] [Abstract][Full Text] [Related]
2. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Unal S; Aydin M; Akin A
Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
Wong CK; Harding GK; Ronald AR; Hoban S
Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
[TBL] [Abstract][Full Text] [Related]
6. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone.
DuPont HL; Reves RR; Galindo E; Sullivan PS; Wood LV; Mendiola JG
N Engl J Med; 1982 Sep; 307(14):841-4. PubMed ID: 7050714
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora.
Stamey TA; Condy M; Mihara G
N Engl J Med; 1977 Apr; 296(14):780-3. PubMed ID: 320482
[TBL] [Abstract][Full Text] [Related]
8. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
[TBL] [Abstract][Full Text] [Related]
9. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
Obaseiki-Ebor EE
Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
12. Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico.
Huang DB; Jiang ZD; Ericsson CD; Adachi J; Dupont HL
Scand J Infect Dis; 2001; 33(11):812-4. PubMed ID: 11760159
[TBL] [Abstract][Full Text] [Related]
13. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
Pancoast SJ; Hyams DM; Neu HC
Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
[TBL] [Abstract][Full Text] [Related]
14. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
15. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL
J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
[TBL] [Abstract][Full Text] [Related]
16. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections.
Kahlmeter G; Menday P
J Antimicrob Chemother; 2003 Jul; 52(1):128-31. PubMed ID: 12805266
[TBL] [Abstract][Full Text] [Related]
18. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
Bailey RR; Peddie BA
N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
[No Abstract] [Full Text] [Related]
19. Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals.
Ho PL; Wong RC; Chow KH; Que TL
Lett Appl Microbiol; 2009 Nov; 49(5):627-34. PubMed ID: 19780962
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S
Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
